1-4 of 4
Authors: Miguel Salavert
Sort by
Journal Article
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study
Rosa Escudero-Sanchez and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 7, July 2022, Pages 1996–2002, https://doi.org/10.1093/jac/dkac106
Published: 11 April 2022
Journal Article
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study
Tanya Babich and others
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 8, August 2021, Pages 2172–2181, https://doi.org/10.1093/jac/dkab134
Published: 16 May 2021
Journal Article
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Celia Cardozo and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 3, March 2020, Pages 730–737, https://doi.org/10.1093/jac/dkz491
Published: 09 December 2019
Journal Article
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences
José Ramón Santos and others
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 11, November 2015, Pages 3087–3095, https://doi.org/10.1093/jac/dkv205
Published: 30 July 2015
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals